CompletedEUCTR 2008-005354-20
Vortioxetine for depression
This study is completed in France, in the United Kingdom, in Belgium, .... It is testing vortioxetine for depression.
In BelgiumDepressionOther
Study directory
Back to overviewMental health studies with practical context.
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
CompletedNCT00706654
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in people with Schizophrenia
This summary needs review. Please check the official study record and contact the research team for details.
In BelgiumSchizophreniaDrugA study involving a medication or substance.From 18 Years to 60 Years
CompletedEUCTR 2016-001715-21
Intravenous ketamine for treatment-resistant depression
This study is completed in Belgium. It is testing intravenous ketamine for treatment-resistant depression.
In BelgiumDepression, BipolarityOther
CompletedNCT01323205
Investigation of the Safety, Tolerability and Potential Therapeutic Effects of JNJ-40411813 in people with Schizophrenia
This study is completed in Belgium, in Austria, in Bulgaria, .... It focuses on schizophrenia.
In BelgiumSchizophreniaDrugFrom 18 Years to 65 Years
CompletedEUCTR 2005-004621-25
Is premorbid functioning a predictor of outcome in people with early onset psychosis treated with Risperdal Consta?
This summary needs review. Please check the official study record and contact the research team for details.
In BelgiumSchizophreniaOther
CompletedNCT00145444
Kahn Study; Investigation Of The Efficacy Of Ziprasidone Versus Olanzapine In The Management Of Recent-Onset Psychosis; A Flexible-Dose, Parallel Group, Study
This study is completed in Belgium and in the Netherlands. It focuses on Schizophrenia.
In BelgiumSchizophreniaDrugFrom 18 Years to 40 Years
CompletedNCT01328756
Lisdexamfetamine Dimesylate 2-year Safety Study in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)
This study exists to understand how a medication treatment holds up over time after the earliest research stage. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.
In BelgiumADHDDrugFrom 6 Years to 17 Years
CompletedNCT01879254
Long-term Follow-up in people with Deep Brain Stimulation (DBS) for OCD (OCD).
This summary needs review. Please check the official study record and contact the research team for details.
In BelgiumOCDDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 65 Years
TerminatedEUCTR 2011-004327-13
Safety study of pomaglumetad Methionil in schizophrenia
This study was terminated in Belgium, in Greece, in Germany, .... It is testing pomaglumetad Methionil for schizophrenia.
In BelgiumSchizophreniaOther
CompletedNCT00190684
Long-Term, Open Label Atomoxetine Study
This summary needs review. Please check the official study record and contact the research team for details.
In BelgiumADHDDrugFrom 6 Years to 18 Years
CompletedEUCTR 2015-002658-11
Long-term, flexible-dose, continuation extension study with vortioxetine in child and adolescent people with Major Depressive Disorder (MDD) from 7 to 17 years of age
This study is completed in France, in the United Kingdom, in Belgium, .... It focuses on depression.
In BelgiumDepressionOther
CompletedEUCTR 2010-024632-42
LY2216684 compared to Placebo as Adjunctive Therapy to SSRI in the Prevention of Symptom Re-emergence in Major Depressive Disorder
This study is completed in Belgium, in Germany, in Slovakia, .... It focuses on depression.
In BelgiumDepressionOther
Public registry coverage is progressing
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.